Assessing the quality of economic evaluations of health care interventions

Annals of Oncology

Volumn 11, Issue 12, 2000, Pages 1513-1515

  Neymark, N ^a  

^a EORTC DATA CENTER   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; HEALTH CARE; HEALTH ECONOMICS; PRIORITY JOURNAL; REVIEW;

COST-BENEFIT ANALYSIS; DRUG INDUSTRY; FINANCING, GOVERNMENT; HISTORY, MODERN 1601-; HUMANS; MODELS, ECONOMETRIC; NEOPLASMS; QUALITY ASSURANCE, HEALTH CARE; RESEARCH DESIGN; RESEARCH SUPPORT;

EID: 0034485764     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008379628096     Document Type: Review

References (13)

1. Economic analysis in randomised control trials
2. Cost-effectiveness and cost-benefit analyses in the medical literature: Are the methods being used correctly?
3. Cost-utility in practice: A policy maker's guide to the state of the art
4. Quality assessment of economic evaluations published in PharmacoEconomics. The first four years (1992-1995)
5. The cost-benefit approach
6. Economic evaluation techniques in health care: Reinventing the wheel?
7. Reporting and dissemination of industry versus non-profit sponsored economic analyses of six novel drugs used in oncology
8. The role of cost-effectiveness analysis in health and medicine
9. Recommendations of the panel on cost-effectiveness in health and medicine
10. Recommendations for reporting cost-effectiveness analysis
11. A tool to improve quality of reporting published economic analyses
12. Guidelines for authors and peer reviewers of economic submissions to BMJ